Capecitabine in Low Risk Triple Negative Breast Cancer

NCT06787339 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
198
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University